Search
Medical science and technologies in Australia

Medical science and technologies in Australia

utility-emailutility-printutility-pdfContact usChange to standard fontChange to large font
Top

Excellent research facilities, world-class scientists, and a strong but flexible regulatory regime are qualities that have made Australia a global leader in medical science and technologies, offering breakthrough research solutions and partnership opportunities.

From the medical use of penicillin and cochlear implants to more recent breakthroughs in cervical cancer and the bionic eye, Australia has a proven track record and is a world-leading destination for medical research including in biotechnology, pharmaceuticals, diagnostics and clinical trials.

Contact an
investment specialist

Case Studies

Success Stories

View all success stories

case-study-default-thumb
Amgen discovers and develops vital medicines Down Under
The US biotech, Amgen, rates Australia as one of the top medical study locations outside the United States.
Read more
Success Story: Carl Zeiss
Carl Zeiss Vision shares Australian research vision
The German optical lens manufacturer is using Australian innovation to both improve the vision of myopia sufferers, and to slow the progression of the condition.
Read more

View all case studies

Investor

Investor update


Australia positions itself for traditional Chinese medicine market
An agreement has been signed in Canberra which will boost Australia’s position in the A$170 billion global traditional Chinese medicine market.
Sysmex accelerates its expansion into Australia’s healthcare market
Japan’s Sysmex Corporation, which develops and manufactures diagnostic products for global markets, is investing A$1.5 million to establish a sales and support office to enhance its presence in Austra ...
GSK expands Australian high-tech manufacturing facility
UK’s GlaxoSmithKline (GSK) will invest A$31 million in new manufacturing technology to expand production of high-quality, low-cost pharmaceutical products at its facility in Boronia, Melbourne.
Australia’s Monash University joins Pfizer research network
Australia’s Monash University has become the first academic research institution outside the United States to be invited to join a collaborative research network set up by biopharmaceutical company Pf ...

more updates

Reports

Reports and
resources

Why Australia - Benchmark Report

Benchmark Report 2014

The Benchmark Report considers the key investor Indicators of Growth, Innovation, Talent, Location, and Business and compares Australia's position with other countries
Benchmark Report

Data Alerts

Data Alerts provide the latest statistics and figures on Australia's performance across key economic and financial related indicators
Data Alerts

Austrade makes no warranty, express or implied as to the fitness for a particular purpose, or assumes any legal liability for the accuracy or usefulness of any information contained in this document. Any consequential loss or damage suffered as a result of reliance on this information is the sole responsibility of the user.